Increasing health concerns about lifestyle disorders, rising awareness about women's health, and growing prevalence of target diseases are some of the key factors driving the market in the country. According to International Osteoporosis Foundation, the estimated prevalence of osteoporosis hip fractures is 2.25 cases per 1,000 population annually in Abu Dhabi.
The UAE pharmaceuticals market is witnessing rapid growth. Although the UAE currently imports the majority of its pharmaceuticals, the scenario is expected to change, as some international pharmaceutical giants have partnered with UAE companies to manufacture products in the country.
Furthermore, the growing pharmaceutical sector in the UAE is another factor fueling the market growth. For instance, in February 2020, Neopharma and GSK plc launched the first locally produced batch of medicines. The main objective of this partnership is to generate manufacturing opportunities in the UAE.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account